Diurnal pattern of insulin action in type 1 diabetes implications for a closed-Loop system

Diabetes

Volumn 62, Issue 7, 2013, Pages 2223-2229

  Hinshaw, Ling ^a   Man, Chiara Dalla ^b   Nandy, Debashis K ^a   Saad, Ahmed ^a   Bharucha, Adil E ^c   Levine, James A ^a   Rizza, Robert A ^a   Basu, Rita ^a   Carter, Rickey E ^c   Cobelli, Claudio ^b   Kudva, Yogish C ^a   Basu, Ananda ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

^c MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CARBOHYDRATE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; TRACER; ANTIDIABETIC AGENT; INSULIN ASPART;

ADULT; ALGORITHM; ARTICLE; ARTIFICIAL PANCREAS; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HORMONE ACTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; MALE; MEAL; MEASUREMENT; MIDDLE AGED; PHYSICAL ACTIVITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT; BLOOD; GLUCOSE BLOOD LEVEL; MOTOR ACTIVITY; PHYSIOLOGY;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN ASPART; MALE; MIDDLE AGED; MOTOR ACTIVITY; POSTPRANDIAL PERIOD;

EID: 84883730627     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-1759     Document Type: Article

References (34)

1. Saad A, Dalla Man C, Nandy DK, et al. Diurnal pattern to insulin secretion and insulin action in healthy individuals. Diabetes 2012;61:2691-2700
2. Malherbe C, De Gasparo M, De Hertogh R, Hoet JJ. Circadian variations of blood sugar and plasma insulin levels in man. Diabetologia 1969;5:397-404
3. Van Cauter E, Shapiro ET, Tillil H, Polonsky KS. Circadian modulation of glucose and insulin responses to meals: relationship to cortisol rhythm. Am J Physiol 1992;262:E467-E475
4. Jarrett RJ, Baker IA, Keen H, Oakley NW. Diurnal variation in oral glucose tolerance: blood sugar and plasma insulin levels morning, afternoon, and evening. BMJ 1972;1:199-201
5. Morgan LM, Aspostolakou F, Wright J, Gama R. Diurnal variations in peripheral insulin resistance and plasma non-esterified fatty acid concentrations: A possible link? Ann Clin Biochem 1999;36:447-450
6. Peter R, Dunseath G, Luzio SD, Chudleigh R, Roy Choudhury S, Owens DR. Daytime variability of postprandial glucose tolerance and pancreatic β-cell function using 12-h profiles in persons with type 2 diabetes. Diabet Med 2010;27:266-273
7. Lee A, Ader M, Bray GA, Bergman RN. Diurnal variation in glucose tolerance. Cyclic suppression of insulin action and insulin secretion in normal-weight, but not obese, subjects. Diabetes 1992;41:750-759
8. Waldhäusl W. Circadian rhythms of insulin needs and actions. Diabetes Res Clin Pract 1989;6:S17-S24
9. Basu R, Di Camillo B, Toffolo G, et al. Use of a novel triple-tracer approach to assess postprandial glucose metabolism. Am J Physiol Endocrinol Metab 2003;284:E55-E69
10. Basu A, Dalla Man C, Basu R, Toffolo G, Cobelli C, Rizza RA. Effects of type 2 diabetes on insulin secretion, insulin action, glucose effectiveness, and postprandial glucose metabolism. Diabetes Care 2009;32:866-872
11. Bharucha AE, Camilleri M, Forstrom LA, Zinsmeister AR. Relationship between clinical features and gastric emptying disturbances in diabetes mellitus. Clin Endocrinol (Oxf) 2009;70:415-420
12. Manohar C, Levine JA, Nandy DK, et al. The effect of walking on postprandial glycemic excursion in patients with type 1 diabetes and healthy people. Diabetes Care 2012;35:2493-2499
13. Owen WE, Roberts WL. Cross-reactivity of three recombinant insulin analogs with five commercial insulin immunoassays. Clin Chem 2004;50:257-259
14. Dalla Man C, Caumo A, Cobelli C. The oral glucose minimal model: estimation of insulin sensitivity from a meal test. IEEE Trans Biomed Eng 2002;49:419-429
15. Dalla Man C, Caumo A, Basu R, Rizza R, Toffolo G, Cobelli C. Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method. Am J Physiol Endocrinol Metab 2004; 287:E637-E643
16. Brown H, Prescott R. Applied Mixed Models in Medicine. 2nd ed. West Sussex, U.K., John Wiley & Sons, 2006
17. Senn SS. Cross-over Trials in Clinical Research. 2nd ed. West Sussex, U.K., John Wiley & Sons, 2002
18. Der G, Everitt BS. Statistical Analysis of Medical Data using SAS. Boca Raton, FL, Chapman and Hall/CRC, 2006
19. Littell RC, Milliken GA, Stroup WW, Wolfinger RD, Scabenberger O. SAS for Mixed Models. Cary, NC, The SAS Institute, 2006
20. Mathiesen ER, Rubin P, Sandahl Christiansen J, Aaby Svendsen P, Lauritzen T, Deckert T. Diurnal pattern of insulin requirements in insulindependent diabetics. Scand J Clin Lab Invest 1982;42:63-68
21. Service FJ, Rizza RA, Hall LD, et al. Prandial insulin requirements in insulin-dependent diabetics: effects of size, time of day, and sequence of meals. J Clin Endocrinol Metab 1983;57:931-936
22. Slama G, Klein JC, Delage A, et al. Correlation between the nature and amount of carbohydrate in meal intake and insulin delivery by the artificial pancreas in 24 insulin-dependent diabetics. Diabetes 1981;30:101- 105
23. Levy-Marchal C, Perlman K, Zinman B, Albisser AM. Preprogrammed intravenous insulin infusion in diabetic humans: metabolic consequences of altering meal size. Diabetes Care 1986;9:283-290
24. Zinman B, Stokes EF, Albisser AM, et al. The metabolic response to glycemic control by the artificial pancreas in diabetic man. Metabolism 1979; 28:511-518
25. Albisser AM, Leibel BS, Ewart TG, et al. Clinical control of diabetes by the artificial pancreas. Diabetes 1974;23:397-404
26. Nosadini R, Noy GA, Nattrass M, et al. The metabolic and hormonal response to acute normoglycaemia in type 1 (insulin-dependent) diabetes: studies with a glucose controlled insulin infusion system (artificial endocrine pancreas). Diabetologia 1982;23:220-228
27. Service FJ. Normalization of plasma glucose of unstable diabetes: studies under ambulatory, fed conditions with pumped intravenous insulin. J Lab Clin Med 1978;91:480-489
28. Werther GA, Turner RC, Jenkins PA, Baum JD. Twenty-four hour profiles of plasma C-peptide in type 1 (insulin-dependent) diabetic children. Diabetologia 1982;22:245-249
29. Bouatia-Naji N, Bonnefond A, Cavalcanti-Proença C, et al. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet 2009;41:89-94
30. Agil A, Rosado I, Ruiz R, Figueroa A, Zen N, Fernández- Vázquez G. Melatonin improves glucose homeostasis in young Zucker diabetic fatty rats. J Pineal Res 2012;52:203-210
31. Jauch-Chara K, Schmid SM, Hallschmid M, Born J, Schultes B. Altered neuroendocrine sleep architecture in patients with type 1 diabetes. Diabetes Care 2008;31:1183-1188
32. Tasali E, Leproult R, Ehrmann DA, Van Cauter E. Slow-wave sleep and the risk of type 2 diabetes in humans. Proc Natl Acad Sci U S A 2008;105:1044-1049
33. Kovatchev BP, Breton M, Man CD, Cobelli C. In silico preclinical trials: A proof of concept in closed-loop control of type 1 diabetes. J Diabetes Sci Tech 2009;3:44-55
34. Kovatchev B, Patek S, Dassau E, et al.; Juvenile Diabetes Research Foundation Artificial Pancreas Consortium. Control to range for diabetes: functionality and modular architecture. J Diabetes Sci Tech 2009;3:1058- 1065